Pacira BioSciences has been granted a patent for a method to treat spasticity in a patient’s limb. The method involves inserting a cryogenic cooling needle near a motor nerve associated with spasticity and delivering a treatment cycle to provide cooling and treat the condition. GlobalData’s report on Pacira BioSciences gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Premium Insights Pacira BioSciences Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Pacira BioSciences, Cancer treatment biomarkers was a key innovation area identified from patents. Pacira BioSciences's grant share as of January 2024 was 52%. Grant share is based on the ratio of number of grants to total number of patents.

Method for treating spasticity in a patient's limb using cryogenic cooling

Source: United States Patent and Trademark Office (USPTO). Credit: Pacira BioSciences Inc

A recently granted patent (Publication Number: US11865038B2) discloses a method for treating spasticity in a patient's limb using a cryogenic cooling needle. The method involves inserting the needle through the skin surface to target tissue near a motor nerve associated with the spasticity. By delivering a treatment cycle with a cooling phase, the liquid from the cooling fluid vaporizes within the needle to provide cooling to the nerve, effectively treating the spasticity. The needle's varying stiffness, flexibility, and bending strength at different portions allow for precise positioning and treatment of the nerve.

Furthermore, the method includes features such as a controlled treatment cycle by a processor, error flag response, temperature measurement with a sensor, and modulation of cooling fluid flow rate. The positioning of the needle near the nerve can be verified using anatomical sites, electrical nerve stimulation, or ultrasound. The cooling phase generates a cryozone of specific volume and duration, ensuring effective treatment. Additionally, the method involves thawing the tissue post-treatment to safely remove the needle without disrupting the target tissue. These innovative features make the method a promising approach for treating spasticity in patients, particularly in upper limbs, with a focus on precision, safety, and efficacy.

To know more about GlobalData’s detailed insights on Pacira BioSciences, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies